Role of tumor necrosis factor-α in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice

American Journal of Pathology

Volumn 151, Issue 5, 1997, Pages 1303-1310

  Thrall, Roger S ^a,d   Vogel, Stefanie N ^b   Evans, Robert ^c   Shultz, Leonard D ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c JACKSON LABORATORY   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN SYNTHESIS; IMMUNOPATHOGENESIS; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CHIMERA; IMMUNE TOLERANCE; IMMUNIZATION, PASSIVE; IMMUNOENZYME TECHNIQUES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PULMONARY FIBROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030694301     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL: "Viable Motheaten", a new allele at the motheaten locus: I. Pathology. Am J Pathol 1984, 116:179-192
2. Shultz LD, Green MC: Motheaten, an immunodeficient mutant of the mouse: II. Depressed immune function and elevated serum immunoglobulins. J Immunol 1976, 116:936-943
3. Sidman CL, Shultz LD, Unanue ER: The mouse mutant motheaten: II. Functional studies of the immune system. J Immunol 1978, 121:2399-2404
4. Davidson WF, Morse HC III, Sharrow SO, Chused TM: Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes. J Immunol 1979, 122:884-891
5. Clark EA, Shultz LD, Pollack SB: Mutations in mice that influence natural killer (NK) cell activity. Immunogenetics 1981, 12:601-613
6. Shultz LD, Zurier RB: "Motheaten", a single gene model for stem cell dysfunction, and early onset autoimmunity. Genetic Control of Autoimmune Disease: Edited by NR Rose, PE Bigazzi, NL Warner. Amsterdam, Elsevier/North Holland, 1978, pp 229-240
7. Ward JM: Pulmonary pathology of the motheaten mouse. Vet Pathol 1978, 15:170-178
8. Rossi GA, Hunninghake GW, Kawanami O, Ferrans VJ, Hansen CT, Crystal RG: Motheaten mice - an animal model with an inherited form of interstitial lung disease. Am Rev Respir Dis 1985, 131:150-158
9. Spencer H: Interstitial pneumonia. Annu Rev Med 1967, 18:423-442
10. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY: Idiopathic pulmonary fibrosis: clinical, histologic, radiologic, physiologic, scintigraphic, cytologic and biochemical aspects. Ann Intern Med 1976, 85:769-776
11. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR: Mutations at the murine motheaten locus are within the hemoatopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993, 73:1445-1454
12. Beutler B, Cerami A: Cachectin: more than a tumor necrosis factor. N Engl J Med 1987, 316:379-385
13. Schollmeier K: Immunologic and pathophysiologic role of tumor necrosis factor. Am J Respir Cell Mol Biol 1990, 3:11-12
14. Kawakami M, Cerami A: Studies of endotoxin induced decrease in lipoprotein lipase activity. J Exp Med 1981, 154:631-636
15. Holler E, Kolb HJ, Moeller A, Kempeni J, Gleixner B, Wilimanns W: Increased levels of tumor necrosis factor a precede major complications of bone marrow transplantation. Blood 1990, 75:1011-1016
16. Michie HR, Manoque KR, Spriggs DR, Revhaug R, O'Dwyer S, Dinarello CA, Gerami A, Wolff SM, Wilmore DW: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988, 318:1481-1486
17. Taskashima T, Ueta C, Tsuyuguchi I, Kishimuto S: Production of tumor necrosis factor α by monocytes from patients with pulmonary tuberculosis. Infect Immun 1990, 58:3286-3292
18. Bachwich PR, Lynch III JP, Larrick J, Spengler M, Kunkel SL: Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986, 125:421-425
19. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P: Tumor necrosis factor/cachectin plays a key role in bleomycin induced pneumopathy and fibrosis. J Exp Med 1989, 170:655-663
20. Tracey KJ, Lowry SF, Cerami A: Cachectin/TNF-α in septic shock, and septic adult respiratory distress syndrome. Am Rev Respir Dis 1988, 138:1377-1379
21. Elias JA, Freundlich B, Kern JA, Rosenbloom J: Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990, 97:1439-1445
22. Millar AB, Singer M, Meagher A, Foley NM, Johnson NMcI, Rook GAW: Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989, 2:712-714
23. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark I, Hariri RJ Fahey III TJ, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 1986, 234:470-474
24. Piguet PF Collart MA, Grau GE, Sappino AP, Vassalli P: Requirement of tumour necrosis factor for development of silica induced pulmonary fibrosis. Nature 1990, 344:245-247
25. Lillie RD: Histopathology Technic and Practical Histochemistry. New York, Blakiston, 1954
26. Woessner JF: The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961, 93:440-447
27. Eilers RJ: Notification of final adoption of an international method and standard solution for hemoglobinometry specifications for preparation of standard solution. Am J Clin Pathol 1967, 47:212-214
28. Hogan MM, Vogel SN: Measurement of Tumor Necrosis Factor α and β Current Protocols in Immunology, vol I. Edited by JE Coligan, AM Kruisbeek, DH Margulies, EM Shevach, W Strober. New York, Greene Publishing Association and Wiley-Interscience, 1992, pp 6.10.1-6.10.5
29. Thrall RS Barton RW, D'Amato DA, Sulavik SB: Differential cellular analysis of bronchoalveolar lavage fluid obtained at various stages during the development of bleomycin induced pulmonary fibrosis in the rat. Am Rev Respir Dis 1982, 126:488-492
30. Shultz LD, Bailey CL, Coman DR: Hematopoietic stem cell function in motheaten mice. Exp Hematol 1983, 11:667-680
31. Colton T (Ed): Inference of means. Statistics in Medicine. Boston, Little, Brown, 1974, pp 99-150
32. Edwards III CK, Su X, Zhou T, Mountz JD: Improved survival and decreased inflammatory lung and skin diseases in motheaten mice by treatment of TNF binding protein. FASEB J 1996, 10:A1330
33. Bissonnette E, Rola-Pleszczynski M: Pulmonary inflammation and fibrosis in a murine model of asbestosis and silicosis. Inflammation 1989, 13:329-339
34. Piguet PF, Vesin C: Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 1994, 7:515-518
35. Miyazaki Y, Tashiro T, Higuchi Y, Setoguchi M, Yamamoto S, Nagai H, Nasu M, Vassalli P: Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-α transgene. Ann NY Acad Sci 1995, 760:334-341
36. Shen SH Bastien L, Posner BI, Chretien P: A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 1991, 352:736-739
37. Zhao Z Bouchard P, Diltz CD, Shen SH, Fischer EH: Purification and characterization of a protein tyrosine phosphatase containing SH2 domains. J Biol Chem 1993, 268:2816-2820
38. Yi T, Cleveland JL, Ihle JN: Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification. Blood 1991, 78:2222-2228
39. Matthews RJ, Bowne DB, Flores E, Thomas ML: Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in praline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992, 12:2396-2405
40. Plutzky J, Neel BG, Rosenberg RD: Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 1992, 891123-1127
41. Plutzky J, Neel BG, Rosenberg RD, Eddy RL, Byers MG, Jani-Sait S, Shows TB: Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6). Genomics 1992, 13:869-872
42. Adachi M, Fischer EH, Ihle J, Imai K, Jirik F, Neel B, Pawson T, Shen SH, Thomas M, Ullrich A, Zhao Z: Mammalian SH2-containing protein tyrosine phosphatases. Cell 1996, 85:15
43. Kozlowski M, Mlinaric-Rascan I, Feng GS, Shen R, Pawson T, Siminovitch KA: Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med 1993, 178:2157-1263
44. Jiao H, Yang W, Berrada K, Tabrizi M, Shultz L, Yi T: Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. Exp Hematol 1997, 25:592-600
45. Chen HE, Chang S, Trub T, Neel BG: Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1996, 16:3685-3697
46. Evans R, Kamdar SJ, Duffy TM, Fuller J: Synergistic interaction of bacterial lipopolysaccharide and the menocyte-macrophage colony stimulating factor: potential quantitative and qualitative changes in macrophage-produced cytokine bioactivity. J Leukocyte Biol 1992, 51:93-96
47. Koo GC, Manyak CL, Dasch J, Ellingsworth L, Shultz LD: Suppressive effects of monocytic cells and transforming growth factor-β on natural killer cell differentiation in autoimmune viable motheaten mutant mice. J Immunol 1991, 147:1194-1200
48. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 1993, 260:536-539
49. Kitagawa S, Yagisawa YA, Azuma E, Yoshida M, Furnukawa Y, Takahashi M, Masuyama J, Takak F: Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release. Exp Hematol 1996, 24:559-567
50. Niwa Y, Dzaki Y, Kanoh T, Akamatsu H, Kurisaka M: Role of cytokines, tyrosine kinase, and protein kinase C on production of superoxide and induction of scavenging enzymes in human leukocytes. Clin Immunol Immunopathol 1996, 79:303-313
51. Barber SA, Perera PY, McNally R, Vogel SN: The serine/threonine phosphatase inhibitor, calyculin A, inhibits and dissociates macrophage responses to lipopolysaccharide. J Immunol 1995, 155:1404-1410
52. Berber SA, Salkowski CA, Fultz MJ, Perera P-Y, McNally R, Vogel SN: Regulation of gene expression and nitric oxide production in murine macrophages by the serine/threonine phosphatase inhibitor okadaic acid. J Endo Res 1996, 3:19-27
53. Sung SJ, Walters JA, Fu SM: Stimulation of tumor necrosis factor-α production in human monocytes by inhibitors of protein phosphatase 1 and 2A. J Exp Med 1992, 176:897-901
54. Geppert TD, Whitehurst CE, Thompson P, Beutler B: Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the Ras/Raf-1 MEK/MAPK pathway. Mol Med 1994, 1:93-97
55. Callaghan MM, Louis RM, Rammohan C, Pope RM: Autocrine regulation of collagenase gene expression by TNF α in U937 cells. J Leukocyte Biol 1996, 59:125-132
56. Chou DH, Lee W, McCulloch CA: TNF-α inactivation of collagen receptors: implications for fibroblast function and fibrosis. J Immunol 1996, 156:4354-4362